BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Hepatitis
,
Stem cell
,
Nosology
,
Tamoxifen
,
IGF1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
claudin‑1
Summary
General Info
Curated Studies
Most Correlated Studies
Liver tumor and non-tumor biopsies of patients with HCV-associated hepatocellular carcinoma
Breast adenocarcinoma MCF7 cells treated with delta-2-troglitazone
Early and late passage of Madin-Darby canine kidney (MDCK) cells
Regulation of gene expression in response to CLDN1 overexpression
Breast cancer cell lines stratified by ER and HER2 biomarker statuses
Explore Curated Studies Results
Literature
Most Relevant Literature
Downregulation of CLDN1 impairs trophoblast invasion and endovascular trophoblast differentiation in…
LIN28B promotes cell invasion and colorectal cancer metastasis via CLDN1 and NOTCH3.
TNF-α induces Claudin-1 expression in renal tubules in Alport mice.
Evaluating the Correlation of Hedgehog Pathway with Claudin-1 Expression in Invasive Breast Cancer.
Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Role of Urinary Claudin-2, Caveolin-1, and EGF as Diagnostic Biomarkers of Necrotizing Enterocolitis…
TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3)
Study of SYSA1801 in the Treatment of Claudin( CLDN) 18.2 Positive Advanced Malignant Solid Tumor
Dose Escalation and Expansion Study of CPO102, an Anti-claudin 18.2 ADC in Patients With Advanced Ca…
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ